Add Journal to My Library
Interactive CardioVascular and Thoracic Surgery
, Volume Advance Article – May 9, 2018

6 pages

/lp/ou_press/is-surgical-apgar-score-an-effective-assessment-tool-for-the-mIVYmy7wYj

- Publisher
- Oxford University Press
- Copyright
- © The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
- ISSN
- 1569-9293
- eISSN
- 1569-9285
- D.O.I.
- 10.1093/icvts/ivy148
- Publisher site
- See Article on Publisher Site

Abstract A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was whether the surgical Apgar score (SAS) was an effective assessment tool for the prediction of postoperative complications in patients undergoing oesophagectomy. In total, 7 papers were identified using the reported search, of which 6 cohort studies represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Five of 6 cohort studies demonstrated that a low SAS was significantly associated with more postoperative complications in patients undergoing oesophagectomy. The rates of major individual complications in patients with a lower SAS were commonly higher than those in patients with a higher SAS. Two cohort studies further reported that a low SAS was significantly associated with the prolonged length of stay. The cut-off value of the SAS that had the discriminative power for patients who were considered at high morbidity risk, however, was not defined but was more likely to be 6 or less. Current available evidence suggests that the SAS system may serve as an effective assessment tool for the prediction of morbidity risk after oesophagectomy. Surgical Apgar score , Oesophagectomy , Morbidity , Prediction INTRODUCTION A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1]. THREE-PART QUESTION In [patients undergoing esophagectomy], can [surgical Apgar score] predict the occurrence of [postoperative complications]? CLINICAL SCENARIO You are working at the thoracic surgery department of a high-volume national cancer centre. You are asked, by relatives, about likely outcomes of a patient who has underwent an oesophagectomy. A colleague suggests that the surgical Apgar score (SAS), which consists of 3 major intraoperative parameters [i.e. estimated intraoperative blood loss (EIBL), lowest mean arterial pressure and the lowest heart rate], may help to predict morbidity risk [2]. You are unfamiliar with this SAS tool in oesophagectomy. You resolve to search the literature and review the best evidence available. SEARCH STRATEGY A comprehensive literature search was conducted on MEDLINE and Embase databases from 1950 to October 2017 using the PubMed interface. Search strategy employed: [esophagectomy] OR [oesophagectomy] OR [esophageal resection] AND [surgical Apgar score]. SEARCH OUTCOME Seven papers were identified using the reported search. From these, 6 papers were identified that provided the best evidence to answer the question. These are presented in Table 1. Table 1: Best evidence papers Author, date, journal and country Study type (level of evidence) Patient group Outcomes Key results Comments Janowak et al. (2015), J Thorac Cardiovasc Surg, USA [3] Retrospective cohort study (level III) Study period: 2009–2013 Total sample size: n = 168 Male/female: 122/46 Mean age: 65 ± 10 years Comorbidity: overall, n = 83; pulmonary, n = 23; cardiovascular, n = 58 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 69; hybrid, n = 83; MIO, n = 16 SAS point assignment criteria: 0 point: EIBL >300 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–300 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 151–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤150 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS ≤6): n = 82 Group B (SAS >6): n = 86 Overall morbidity (defined as the NSQIP adverse events) 30-Day mortality Pneumonia Anastomotic leakage Surgical site infection Clavien–Dindo Grade III–IV complications Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 34.5% (n = 58) Group A: 37/82 (45.1%) Group B: 21/86 (24.4%) P = 0.005 Rate = 2.4% (n = 4) Group A: 3/82 (3.7%) Group B: 1/86 (1.2%) P = 0.36 Rate = 13.7% (n = 23) Group A: 15/82 (18.3%) Group B: 8/86 (9.3%) P = 0.11 Rate = 15.5% (n = 26) Group A: 16/82 (19.5%) Group B: 10/86 (11.6%) P = 0.20 Rate = 17.9% (n = 30) Group A: 19/82 (23.2%) Group B: 11/86 (12.8%) P = 0.11 Rate = 13.7% (n = 23) Group A: 14/82 (17.1%) Group B: 9/86 (10.5%) P = 0.26 Rate = 3.0% (n = 5) Group A: 4/82 (4.9%) Group B: 1/86 (1.2%) P = 0.20 SAS ≤6 vs SAS >6: OR 3.75, 95% CI 1.70–8.26; P = 0.001 First article to demonstrate the predictive value of the SAS system in oesophagectomy Eto et al. (2016), World J Surg, Japan [4] Retrospective cohort study (level III) Study period: 2007–2015 Total sample size: n = 399 Male/female: 357/42 Mean age: 65.7 ± 0.6 years Comorbidity: overall, n = 286 Diagnosis: oesophageal malignancy Operative procedures: thoracoscopic assist, n = 354; laparoscopic assist, n = 124 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS <6): n = 154 Group B (SAS ≥6): n = 245 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Anastomotic leakage Surgical site infection Recurrent laryngeal nerve paralysis Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 31.6% (n = 126) Group A: 71/154 (46.1%) Group B: 55/245 (22.4%) P < 0.001 Rate = 12.5% (n = 50) Group A: 29/154 (18.8%) Group B: 21/245 (8.3%) P = 0.003 Rate = 12.8% (n = 51) Group A: 32/154 (20.8%) Group B: 19/245 (7.8%) P < 0.001 Rate = 19.5% (n = 78) Group A: 47/154 (30.5%) Group B: 31/245 (12.7%) P < 0.001 Rate = 4.0% (n = 16) Group A: 9/154 (5.8%) Group B: 7/245 (2.9%) P = 0.15 Rate = 2.3% (n = 9) Group A: 6/154 (3.9%) Group B: 3/245 (1.2%) P = 0.090 SAS <6 vs SAS ≥6: OR 2.88, 95% CI 1.69–4.97; P < 0.001 The low SAS was predictive of major morbidity after oesophageal cancer resections Giugliano et al. (2017), J Surg Oncol, Japan [5] Retrospective cohort study (level III) Study period: 2005–2014 Total sample size: n = 212 Male/female: 175/37 Mean age: 63.5 (31–86) years Comorbidity: no data reported Diagnosis: oesophageal malignancy, n = 191; dysplasia of oesophagus, n = 9; other non-malignancy diseases, n = 12 Operative procedures: thoracotomy, n = 45; transhiatal, n = 40; MIO, n = 127 SAS point assignment criteria: 0 point: EIBL >400 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–400 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 100–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL<100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: SAS 0–2: n = 5 SAS 3–4: n = 23 SAS 5–6: n = 81 SAS 7–8: n = 96 SAS 9–10: n = 7 Clavien–Dindo Grade ≥II complications Clavien–Dindo Grade ≥III complications Anastomotic leakage Length of stay Multivariate analysis of each one SAS category increase for predicting postoperative outcomes Rate = 52.4% (n = 147) 0–2: 5/5 (100%) 3–4: 17/23 (73.9%) 5–6: 45/81 (55.6%) 7–8: 43/96 (44.8%) 9–10: 1/7 (14.3%) P < 0.001 Rate = 31.6% (n = 67) 0–2: 3/5 (60%) 3–4: 15/23 (65.2%) 5–6: 27/81 (33.3%) 7–8: 22/96 (22.9%) 9–10: 0/7 (0.0%) P < 0.001 Rate = 17.9% (n = 38) 0–2: 2/5 (40%) 3–4: 6/23 (26.1%) 5–6: 12/81 (14.8%) 7–8: 17/96 (17.7%) 9–10: 1/7 (14.3%) P = 0.29 Overall: media n = 10 days; range = 1–87 days 0–2: median = 20 days 3–4: median = 16 days 5–6: median = 10 days 7–8: median = 9 days 9–10: median = 8 days P < 0.001 Clavien–Dindo Grade ≥II complications: OR 0.53, 95% CI 0.35–0.79; P = 0.002 Clavien–Dindo Grade ≥III complications: OR 0.50, 95% CI 0.33–0.76; P = 0.001 Anastomotic leakage: OR 0.88, 95% CI 0.56–1.40; P = 0.59 In-hospital mortality: OR 0.40, 95% CI 0.19–0.86; P = 0.019 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay Nakagawa et al. (2017), Ann Surg Oncol, Japan [6] Retrospective cohort study (level III) Study period: 2007–2017 Total sample size: n = 400 Male/female: 338/62 Mean age: no data reported Comorbidity: hypertension, n = 89; diabetes, n = 28; respiratory dysfunction, n = 72 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 38; MIO, n = 362 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 5 Group A (SAS ≤5): n = 181 Group B (SAS >5): n = 219 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Gastrointestinal complications Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 36.3% (n = 145) Group A: 90/181 (49.7%) Group B: 55/219 (25.1%) P < 0.001 Rate = 15.0% (n = 60) Group A: 39/181 (21.5%) Group B: 21/219 (9.6%) P = 0.001 Rate = 19.0% (n = 76) Group A: 45/181 (24.9%) Group B: 31/219 (14.2%) P = 0.008 SAS ≤5 vs SAS >5 Overall morbidity: OR 2.86, 95% CI 1.85–4.41; P < 0.001 Respiratory complications: OR 2.23, 95% CI 1.21–4.10; P = 0.010 Gastrointestinal complications: OR 1.75, 95% CI 1.04–2.95; P = 0.035 There was a significant correlation between the low SAS and both in-hospital morbidity and long-term prognosis after oesophagectomy Strøyer et al. (2017), J Surg Oncol, Denmark [7] Retrospective cohort study (level III) Study period: 2011–2014 Total sample size: n = 234 Male/female: 191/43 Mean age: 65 (58–70) years Comorbidity: COPD, n = 11; diabetes, n = 40; cardiovascular, n = 47 Diagnosis: oesophagogastric junction adenocarcinoma Operative procedures: thoracotomy, n = 193; robotically assisted procedure, n = 41 SAS point assignment criteria: 0 point: EIBL >75th percentile, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL >median-75th percentile, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL >25th percentile-median, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤25th percentile, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Group A (with morbidity): n = 64 Group B (without morbidity): n = 170 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Multivariate analysis of each one SAS category increase for predicting postoperative morbidity Rate = 27.4% (n = 64) Group A: median SAS = 6 (5–7) Group B: median SAS = 6 (5–7) P = 0.084 OR = 0.84; 95% CI = 0.68–1.03; P = 0.096 No difference in the modified SAS between patients with morbidity and without morbidity Xing et al. (2016), J Thorac Dis, China [8] Retrospective cohort study (level III) Study period: 2008–2010 Total sample size: n = 189 Male/female: 161/28 Mean age: 64.6 ± 9.6 years Comorbidity: hypertension, n = 41; diabetes, n = 11; coronary heart disease, n = 11; COPD, n = 3 Diagnosis: oesophageal malignancy Operative procedures: all thoracotomy SAS point assignment criteria: 0 point: EIBL >600 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 301–600 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 201–300 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤200 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 7 Group A (SAS ≤7): n = 156 Group B (SAS >7): n = 33 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Length of stay In-hospital mortality Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 58.2% (n = 110) Group A: 99/156 (63.5%) Group B: 11/33 (33.3%) P = 0.001 Group A: 32.2 ± 22.7 days Group B: 25.4 ± 14.4 days P = 0.030 Rate = 6.9% (n = 13) Group A: 12/156 (7.7%) Group B: 1/33 (3.0%) P = 0.47 SAS ≤7 vs SAS >7: OR = 2.81; 95% CI = 1.11–7.14; P = 0.030 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay Author, date, journal and country Study type (level of evidence) Patient group Outcomes Key results Comments Janowak et al. (2015), J Thorac Cardiovasc Surg, USA [3] Retrospective cohort study (level III) Study period: 2009–2013 Total sample size: n = 168 Male/female: 122/46 Mean age: 65 ± 10 years Comorbidity: overall, n = 83; pulmonary, n = 23; cardiovascular, n = 58 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 69; hybrid, n = 83; MIO, n = 16 SAS point assignment criteria: 0 point: EIBL >300 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–300 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 151–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤150 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS ≤6): n = 82 Group B (SAS >6): n = 86 Overall morbidity (defined as the NSQIP adverse events) 30-Day mortality Pneumonia Anastomotic leakage Surgical site infection Clavien–Dindo Grade III–IV complications Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 34.5% (n = 58) Group A: 37/82 (45.1%) Group B: 21/86 (24.4%) P = 0.005 Rate = 2.4% (n = 4) Group A: 3/82 (3.7%) Group B: 1/86 (1.2%) P = 0.36 Rate = 13.7% (n = 23) Group A: 15/82 (18.3%) Group B: 8/86 (9.3%) P = 0.11 Rate = 15.5% (n = 26) Group A: 16/82 (19.5%) Group B: 10/86 (11.6%) P = 0.20 Rate = 17.9% (n = 30) Group A: 19/82 (23.2%) Group B: 11/86 (12.8%) P = 0.11 Rate = 13.7% (n = 23) Group A: 14/82 (17.1%) Group B: 9/86 (10.5%) P = 0.26 Rate = 3.0% (n = 5) Group A: 4/82 (4.9%) Group B: 1/86 (1.2%) P = 0.20 SAS ≤6 vs SAS >6: OR 3.75, 95% CI 1.70–8.26; P = 0.001 First article to demonstrate the predictive value of the SAS system in oesophagectomy Eto et al. (2016), World J Surg, Japan [4] Retrospective cohort study (level III) Study period: 2007–2015 Total sample size: n = 399 Male/female: 357/42 Mean age: 65.7 ± 0.6 years Comorbidity: overall, n = 286 Diagnosis: oesophageal malignancy Operative procedures: thoracoscopic assist, n = 354; laparoscopic assist, n = 124 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS <6): n = 154 Group B (SAS ≥6): n = 245 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Anastomotic leakage Surgical site infection Recurrent laryngeal nerve paralysis Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 31.6% (n = 126) Group A: 71/154 (46.1%) Group B: 55/245 (22.4%) P < 0.001 Rate = 12.5% (n = 50) Group A: 29/154 (18.8%) Group B: 21/245 (8.3%) P = 0.003 Rate = 12.8% (n = 51) Group A: 32/154 (20.8%) Group B: 19/245 (7.8%) P < 0.001 Rate = 19.5% (n = 78) Group A: 47/154 (30.5%) Group B: 31/245 (12.7%) P < 0.001 Rate = 4.0% (n = 16) Group A: 9/154 (5.8%) Group B: 7/245 (2.9%) P = 0.15 Rate = 2.3% (n = 9) Group A: 6/154 (3.9%) Group B: 3/245 (1.2%) P = 0.090 SAS <6 vs SAS ≥6: OR 2.88, 95% CI 1.69–4.97; P < 0.001 The low SAS was predictive of major morbidity after oesophageal cancer resections Giugliano et al. (2017), J Surg Oncol, Japan [5] Retrospective cohort study (level III) Study period: 2005–2014 Total sample size: n = 212 Male/female: 175/37 Mean age: 63.5 (31–86) years Comorbidity: no data reported Diagnosis: oesophageal malignancy, n = 191; dysplasia of oesophagus, n = 9; other non-malignancy diseases, n = 12 Operative procedures: thoracotomy, n = 45; transhiatal, n = 40; MIO, n = 127 SAS point assignment criteria: 0 point: EIBL >400 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–400 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 100–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL<100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: SAS 0–2: n = 5 SAS 3–4: n = 23 SAS 5–6: n = 81 SAS 7–8: n = 96 SAS 9–10: n = 7 Clavien–Dindo Grade ≥II complications Clavien–Dindo Grade ≥III complications Anastomotic leakage Length of stay Multivariate analysis of each one SAS category increase for predicting postoperative outcomes Rate = 52.4% (n = 147) 0–2: 5/5 (100%) 3–4: 17/23 (73.9%) 5–6: 45/81 (55.6%) 7–8: 43/96 (44.8%) 9–10: 1/7 (14.3%) P < 0.001 Rate = 31.6% (n = 67) 0–2: 3/5 (60%) 3–4: 15/23 (65.2%) 5–6: 27/81 (33.3%) 7–8: 22/96 (22.9%) 9–10: 0/7 (0.0%) P < 0.001 Rate = 17.9% (n = 38) 0–2: 2/5 (40%) 3–4: 6/23 (26.1%) 5–6: 12/81 (14.8%) 7–8: 17/96 (17.7%) 9–10: 1/7 (14.3%) P = 0.29 Overall: media n = 10 days; range = 1–87 days 0–2: median = 20 days 3–4: median = 16 days 5–6: median = 10 days 7–8: median = 9 days 9–10: median = 8 days P < 0.001 Clavien–Dindo Grade ≥II complications: OR 0.53, 95% CI 0.35–0.79; P = 0.002 Clavien–Dindo Grade ≥III complications: OR 0.50, 95% CI 0.33–0.76; P = 0.001 Anastomotic leakage: OR 0.88, 95% CI 0.56–1.40; P = 0.59 In-hospital mortality: OR 0.40, 95% CI 0.19–0.86; P = 0.019 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay Nakagawa et al. (2017), Ann Surg Oncol, Japan [6] Retrospective cohort study (level III) Study period: 2007–2017 Total sample size: n = 400 Male/female: 338/62 Mean age: no data reported Comorbidity: hypertension, n = 89; diabetes, n = 28; respiratory dysfunction, n = 72 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 38; MIO, n = 362 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 5 Group A (SAS ≤5): n = 181 Group B (SAS >5): n = 219 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Gastrointestinal complications Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 36.3% (n = 145) Group A: 90/181 (49.7%) Group B: 55/219 (25.1%) P < 0.001 Rate = 15.0% (n = 60) Group A: 39/181 (21.5%) Group B: 21/219 (9.6%) P = 0.001 Rate = 19.0% (n = 76) Group A: 45/181 (24.9%) Group B: 31/219 (14.2%) P = 0.008 SAS ≤5 vs SAS >5 Overall morbidity: OR 2.86, 95% CI 1.85–4.41; P < 0.001 Respiratory complications: OR 2.23, 95% CI 1.21–4.10; P = 0.010 Gastrointestinal complications: OR 1.75, 95% CI 1.04–2.95; P = 0.035 There was a significant correlation between the low SAS and both in-hospital morbidity and long-term prognosis after oesophagectomy Strøyer et al. (2017), J Surg Oncol, Denmark [7] Retrospective cohort study (level III) Study period: 2011–2014 Total sample size: n = 234 Male/female: 191/43 Mean age: 65 (58–70) years Comorbidity: COPD, n = 11; diabetes, n = 40; cardiovascular, n = 47 Diagnosis: oesophagogastric junction adenocarcinoma Operative procedures: thoracotomy, n = 193; robotically assisted procedure, n = 41 SAS point assignment criteria: 0 point: EIBL >75th percentile, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL >median-75th percentile, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL >25th percentile-median, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤25th percentile, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Group A (with morbidity): n = 64 Group B (without morbidity): n = 170 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Multivariate analysis of each one SAS category increase for predicting postoperative morbidity Rate = 27.4% (n = 64) Group A: median SAS = 6 (5–7) Group B: median SAS = 6 (5–7) P = 0.084 OR = 0.84; 95% CI = 0.68–1.03; P = 0.096 No difference in the modified SAS between patients with morbidity and without morbidity Xing et al. (2016), J Thorac Dis, China [8] Retrospective cohort study (level III) Study period: 2008–2010 Total sample size: n = 189 Male/female: 161/28 Mean age: 64.6 ± 9.6 years Comorbidity: hypertension, n = 41; diabetes, n = 11; coronary heart disease, n = 11; COPD, n = 3 Diagnosis: oesophageal malignancy Operative procedures: all thoracotomy SAS point assignment criteria: 0 point: EIBL >600 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 301–600 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 201–300 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤200 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 7 Group A (SAS ≤7): n = 156 Group B (SAS >7): n = 33 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Length of stay In-hospital mortality Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 58.2% (n = 110) Group A: 99/156 (63.5%) Group B: 11/33 (33.3%) P = 0.001 Group A: 32.2 ± 22.7 days Group B: 25.4 ± 14.4 days P = 0.030 Rate = 6.9% (n = 13) Group A: 12/156 (7.7%) Group B: 1/33 (3.0%) P = 0.47 SAS ≤7 vs SAS >7: OR = 2.81; 95% CI = 1.11–7.14; P = 0.030 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay CI: confidence interval; COPD: chronic obstructive pulmonary disease; EIBL: estimated intraoperative blood loss; LHR: lowest heart rate; LMAP: lowest mean arterial pressure; MIO: minimally invasive oesophagectomy; NSQIP: National Surgical Quality Improvement Program; OR: odds ratio; SAS: surgical Apgar score. Table 1: Best evidence papers Author, date, journal and country Study type (level of evidence) Patient group Outcomes Key results Comments Janowak et al. (2015), J Thorac Cardiovasc Surg, USA [3] Retrospective cohort study (level III) Study period: 2009–2013 Total sample size: n = 168 Male/female: 122/46 Mean age: 65 ± 10 years Comorbidity: overall, n = 83; pulmonary, n = 23; cardiovascular, n = 58 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 69; hybrid, n = 83; MIO, n = 16 SAS point assignment criteria: 0 point: EIBL >300 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–300 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 151–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤150 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS ≤6): n = 82 Group B (SAS >6): n = 86 Overall morbidity (defined as the NSQIP adverse events) 30-Day mortality Pneumonia Anastomotic leakage Surgical site infection Clavien–Dindo Grade III–IV complications Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 34.5% (n = 58) Group A: 37/82 (45.1%) Group B: 21/86 (24.4%) P = 0.005 Rate = 2.4% (n = 4) Group A: 3/82 (3.7%) Group B: 1/86 (1.2%) P = 0.36 Rate = 13.7% (n = 23) Group A: 15/82 (18.3%) Group B: 8/86 (9.3%) P = 0.11 Rate = 15.5% (n = 26) Group A: 16/82 (19.5%) Group B: 10/86 (11.6%) P = 0.20 Rate = 17.9% (n = 30) Group A: 19/82 (23.2%) Group B: 11/86 (12.8%) P = 0.11 Rate = 13.7% (n = 23) Group A: 14/82 (17.1%) Group B: 9/86 (10.5%) P = 0.26 Rate = 3.0% (n = 5) Group A: 4/82 (4.9%) Group B: 1/86 (1.2%) P = 0.20 SAS ≤6 vs SAS >6: OR 3.75, 95% CI 1.70–8.26; P = 0.001 First article to demonstrate the predictive value of the SAS system in oesophagectomy Eto et al. (2016), World J Surg, Japan [4] Retrospective cohort study (level III) Study period: 2007–2015 Total sample size: n = 399 Male/female: 357/42 Mean age: 65.7 ± 0.6 years Comorbidity: overall, n = 286 Diagnosis: oesophageal malignancy Operative procedures: thoracoscopic assist, n = 354; laparoscopic assist, n = 124 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS <6): n = 154 Group B (SAS ≥6): n = 245 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Anastomotic leakage Surgical site infection Recurrent laryngeal nerve paralysis Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 31.6% (n = 126) Group A: 71/154 (46.1%) Group B: 55/245 (22.4%) P < 0.001 Rate = 12.5% (n = 50) Group A: 29/154 (18.8%) Group B: 21/245 (8.3%) P = 0.003 Rate = 12.8% (n = 51) Group A: 32/154 (20.8%) Group B: 19/245 (7.8%) P < 0.001 Rate = 19.5% (n = 78) Group A: 47/154 (30.5%) Group B: 31/245 (12.7%) P < 0.001 Rate = 4.0% (n = 16) Group A: 9/154 (5.8%) Group B: 7/245 (2.9%) P = 0.15 Rate = 2.3% (n = 9) Group A: 6/154 (3.9%) Group B: 3/245 (1.2%) P = 0.090 SAS <6 vs SAS ≥6: OR 2.88, 95% CI 1.69–4.97; P < 0.001 The low SAS was predictive of major morbidity after oesophageal cancer resections Giugliano et al. (2017), J Surg Oncol, Japan [5] Retrospective cohort study (level III) Study period: 2005–2014 Total sample size: n = 212 Male/female: 175/37 Mean age: 63.5 (31–86) years Comorbidity: no data reported Diagnosis: oesophageal malignancy, n = 191; dysplasia of oesophagus, n = 9; other non-malignancy diseases, n = 12 Operative procedures: thoracotomy, n = 45; transhiatal, n = 40; MIO, n = 127 SAS point assignment criteria: 0 point: EIBL >400 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–400 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 100–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL<100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: SAS 0–2: n = 5 SAS 3–4: n = 23 SAS 5–6: n = 81 SAS 7–8: n = 96 SAS 9–10: n = 7 Clavien–Dindo Grade ≥II complications Clavien–Dindo Grade ≥III complications Anastomotic leakage Length of stay Multivariate analysis of each one SAS category increase for predicting postoperative outcomes Rate = 52.4% (n = 147) 0–2: 5/5 (100%) 3–4: 17/23 (73.9%) 5–6: 45/81 (55.6%) 7–8: 43/96 (44.8%) 9–10: 1/7 (14.3%) P < 0.001 Rate = 31.6% (n = 67) 0–2: 3/5 (60%) 3–4: 15/23 (65.2%) 5–6: 27/81 (33.3%) 7–8: 22/96 (22.9%) 9–10: 0/7 (0.0%) P < 0.001 Rate = 17.9% (n = 38) 0–2: 2/5 (40%) 3–4: 6/23 (26.1%) 5–6: 12/81 (14.8%) 7–8: 17/96 (17.7%) 9–10: 1/7 (14.3%) P = 0.29 Overall: media n = 10 days; range = 1–87 days 0–2: median = 20 days 3–4: median = 16 days 5–6: median = 10 days 7–8: median = 9 days 9–10: median = 8 days P < 0.001 Clavien–Dindo Grade ≥II complications: OR 0.53, 95% CI 0.35–0.79; P = 0.002 Clavien–Dindo Grade ≥III complications: OR 0.50, 95% CI 0.33–0.76; P = 0.001 Anastomotic leakage: OR 0.88, 95% CI 0.56–1.40; P = 0.59 In-hospital mortality: OR 0.40, 95% CI 0.19–0.86; P = 0.019 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay Nakagawa et al. (2017), Ann Surg Oncol, Japan [6] Retrospective cohort study (level III) Study period: 2007–2017 Total sample size: n = 400 Male/female: 338/62 Mean age: no data reported Comorbidity: hypertension, n = 89; diabetes, n = 28; respiratory dysfunction, n = 72 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 38; MIO, n = 362 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 5 Group A (SAS ≤5): n = 181 Group B (SAS >5): n = 219 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Gastrointestinal complications Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 36.3% (n = 145) Group A: 90/181 (49.7%) Group B: 55/219 (25.1%) P < 0.001 Rate = 15.0% (n = 60) Group A: 39/181 (21.5%) Group B: 21/219 (9.6%) P = 0.001 Rate = 19.0% (n = 76) Group A: 45/181 (24.9%) Group B: 31/219 (14.2%) P = 0.008 SAS ≤5 vs SAS >5 Overall morbidity: OR 2.86, 95% CI 1.85–4.41; P < 0.001 Respiratory complications: OR 2.23, 95% CI 1.21–4.10; P = 0.010 Gastrointestinal complications: OR 1.75, 95% CI 1.04–2.95; P = 0.035 There was a significant correlation between the low SAS and both in-hospital morbidity and long-term prognosis after oesophagectomy Strøyer et al. (2017), J Surg Oncol, Denmark [7] Retrospective cohort study (level III) Study period: 2011–2014 Total sample size: n = 234 Male/female: 191/43 Mean age: 65 (58–70) years Comorbidity: COPD, n = 11; diabetes, n = 40; cardiovascular, n = 47 Diagnosis: oesophagogastric junction adenocarcinoma Operative procedures: thoracotomy, n = 193; robotically assisted procedure, n = 41 SAS point assignment criteria: 0 point: EIBL >75th percentile, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL >median-75th percentile, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL >25th percentile-median, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤25th percentile, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Group A (with morbidity): n = 64 Group B (without morbidity): n = 170 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Multivariate analysis of each one SAS category increase for predicting postoperative morbidity Rate = 27.4% (n = 64) Group A: median SAS = 6 (5–7) Group B: median SAS = 6 (5–7) P = 0.084 OR = 0.84; 95% CI = 0.68–1.03; P = 0.096 No difference in the modified SAS between patients with morbidity and without morbidity Xing et al. (2016), J Thorac Dis, China [8] Retrospective cohort study (level III) Study period: 2008–2010 Total sample size: n = 189 Male/female: 161/28 Mean age: 64.6 ± 9.6 years Comorbidity: hypertension, n = 41; diabetes, n = 11; coronary heart disease, n = 11; COPD, n = 3 Diagnosis: oesophageal malignancy Operative procedures: all thoracotomy SAS point assignment criteria: 0 point: EIBL >600 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 301–600 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 201–300 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤200 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 7 Group A (SAS ≤7): n = 156 Group B (SAS >7): n = 33 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Length of stay In-hospital mortality Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 58.2% (n = 110) Group A: 99/156 (63.5%) Group B: 11/33 (33.3%) P = 0.001 Group A: 32.2 ± 22.7 days Group B: 25.4 ± 14.4 days P = 0.030 Rate = 6.9% (n = 13) Group A: 12/156 (7.7%) Group B: 1/33 (3.0%) P = 0.47 SAS ≤7 vs SAS >7: OR = 2.81; 95% CI = 1.11–7.14; P = 0.030 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay Author, date, journal and country Study type (level of evidence) Patient group Outcomes Key results Comments Janowak et al. (2015), J Thorac Cardiovasc Surg, USA [3] Retrospective cohort study (level III) Study period: 2009–2013 Total sample size: n = 168 Male/female: 122/46 Mean age: 65 ± 10 years Comorbidity: overall, n = 83; pulmonary, n = 23; cardiovascular, n = 58 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 69; hybrid, n = 83; MIO, n = 16 SAS point assignment criteria: 0 point: EIBL >300 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–300 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 151–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤150 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS ≤6): n = 82 Group B (SAS >6): n = 86 Overall morbidity (defined as the NSQIP adverse events) 30-Day mortality Pneumonia Anastomotic leakage Surgical site infection Clavien–Dindo Grade III–IV complications Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 34.5% (n = 58) Group A: 37/82 (45.1%) Group B: 21/86 (24.4%) P = 0.005 Rate = 2.4% (n = 4) Group A: 3/82 (3.7%) Group B: 1/86 (1.2%) P = 0.36 Rate = 13.7% (n = 23) Group A: 15/82 (18.3%) Group B: 8/86 (9.3%) P = 0.11 Rate = 15.5% (n = 26) Group A: 16/82 (19.5%) Group B: 10/86 (11.6%) P = 0.20 Rate = 17.9% (n = 30) Group A: 19/82 (23.2%) Group B: 11/86 (12.8%) P = 0.11 Rate = 13.7% (n = 23) Group A: 14/82 (17.1%) Group B: 9/86 (10.5%) P = 0.26 Rate = 3.0% (n = 5) Group A: 4/82 (4.9%) Group B: 1/86 (1.2%) P = 0.20 SAS ≤6 vs SAS >6: OR 3.75, 95% CI 1.70–8.26; P = 0.001 First article to demonstrate the predictive value of the SAS system in oesophagectomy Eto et al. (2016), World J Surg, Japan [4] Retrospective cohort study (level III) Study period: 2007–2015 Total sample size: n = 399 Male/female: 357/42 Mean age: 65.7 ± 0.6 years Comorbidity: overall, n = 286 Diagnosis: oesophageal malignancy Operative procedures: thoracoscopic assist, n = 354; laparoscopic assist, n = 124 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 6 Group A (SAS <6): n = 154 Group B (SAS ≥6): n = 245 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Anastomotic leakage Surgical site infection Recurrent laryngeal nerve paralysis Chylothorax Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 31.6% (n = 126) Group A: 71/154 (46.1%) Group B: 55/245 (22.4%) P < 0.001 Rate = 12.5% (n = 50) Group A: 29/154 (18.8%) Group B: 21/245 (8.3%) P = 0.003 Rate = 12.8% (n = 51) Group A: 32/154 (20.8%) Group B: 19/245 (7.8%) P < 0.001 Rate = 19.5% (n = 78) Group A: 47/154 (30.5%) Group B: 31/245 (12.7%) P < 0.001 Rate = 4.0% (n = 16) Group A: 9/154 (5.8%) Group B: 7/245 (2.9%) P = 0.15 Rate = 2.3% (n = 9) Group A: 6/154 (3.9%) Group B: 3/245 (1.2%) P = 0.090 SAS <6 vs SAS ≥6: OR 2.88, 95% CI 1.69–4.97; P < 0.001 The low SAS was predictive of major morbidity after oesophageal cancer resections Giugliano et al. (2017), J Surg Oncol, Japan [5] Retrospective cohort study (level III) Study period: 2005–2014 Total sample size: n = 212 Male/female: 175/37 Mean age: 63.5 (31–86) years Comorbidity: no data reported Diagnosis: oesophageal malignancy, n = 191; dysplasia of oesophagus, n = 9; other non-malignancy diseases, n = 12 Operative procedures: thoracotomy, n = 45; transhiatal, n = 40; MIO, n = 127 SAS point assignment criteria: 0 point: EIBL >400 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 201–400 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 100–200 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL<100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: SAS 0–2: n = 5 SAS 3–4: n = 23 SAS 5–6: n = 81 SAS 7–8: n = 96 SAS 9–10: n = 7 Clavien–Dindo Grade ≥II complications Clavien–Dindo Grade ≥III complications Anastomotic leakage Length of stay Multivariate analysis of each one SAS category increase for predicting postoperative outcomes Rate = 52.4% (n = 147) 0–2: 5/5 (100%) 3–4: 17/23 (73.9%) 5–6: 45/81 (55.6%) 7–8: 43/96 (44.8%) 9–10: 1/7 (14.3%) P < 0.001 Rate = 31.6% (n = 67) 0–2: 3/5 (60%) 3–4: 15/23 (65.2%) 5–6: 27/81 (33.3%) 7–8: 22/96 (22.9%) 9–10: 0/7 (0.0%) P < 0.001 Rate = 17.9% (n = 38) 0–2: 2/5 (40%) 3–4: 6/23 (26.1%) 5–6: 12/81 (14.8%) 7–8: 17/96 (17.7%) 9–10: 1/7 (14.3%) P = 0.29 Overall: media n = 10 days; range = 1–87 days 0–2: median = 20 days 3–4: median = 16 days 5–6: median = 10 days 7–8: median = 9 days 9–10: median = 8 days P < 0.001 Clavien–Dindo Grade ≥II complications: OR 0.53, 95% CI 0.35–0.79; P = 0.002 Clavien–Dindo Grade ≥III complications: OR 0.50, 95% CI 0.33–0.76; P = 0.001 Anastomotic leakage: OR 0.88, 95% CI 0.56–1.40; P = 0.59 In-hospital mortality: OR 0.40, 95% CI 0.19–0.86; P = 0.019 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay Nakagawa et al. (2017), Ann Surg Oncol, Japan [6] Retrospective cohort study (level III) Study period: 2007–2017 Total sample size: n = 400 Male/female: 338/62 Mean age: no data reported Comorbidity: hypertension, n = 89; diabetes, n = 28; respiratory dysfunction, n = 72 Diagnosis: oesophageal malignancy Operative procedures: thoracotomy, n = 38; MIO, n = 362 SAS point assignment criteria: 0 point: EIBL >1000 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 601–1000 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 101–600 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤100 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 5 Group A (SAS ≤5): n = 181 Group B (SAS >5): n = 219 Overall morbidity (defined as the Clavien–Dindo Grade ≥III complications) Respiratory complications Gastrointestinal complications Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 36.3% (n = 145) Group A: 90/181 (49.7%) Group B: 55/219 (25.1%) P < 0.001 Rate = 15.0% (n = 60) Group A: 39/181 (21.5%) Group B: 21/219 (9.6%) P = 0.001 Rate = 19.0% (n = 76) Group A: 45/181 (24.9%) Group B: 31/219 (14.2%) P = 0.008 SAS ≤5 vs SAS >5 Overall morbidity: OR 2.86, 95% CI 1.85–4.41; P < 0.001 Respiratory complications: OR 2.23, 95% CI 1.21–4.10; P = 0.010 Gastrointestinal complications: OR 1.75, 95% CI 1.04–2.95; P = 0.035 There was a significant correlation between the low SAS and both in-hospital morbidity and long-term prognosis after oesophagectomy Strøyer et al. (2017), J Surg Oncol, Denmark [7] Retrospective cohort study (level III) Study period: 2011–2014 Total sample size: n = 234 Male/female: 191/43 Mean age: 65 (58–70) years Comorbidity: COPD, n = 11; diabetes, n = 40; cardiovascular, n = 47 Diagnosis: oesophagogastric junction adenocarcinoma Operative procedures: thoracotomy, n = 193; robotically assisted procedure, n = 41 SAS point assignment criteria: 0 point: EIBL >75th percentile, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL >median-75th percentile, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL >25th percentile-median, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤25th percentile, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Group A (with morbidity): n = 64 Group B (without morbidity): n = 170 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Multivariate analysis of each one SAS category increase for predicting postoperative morbidity Rate = 27.4% (n = 64) Group A: median SAS = 6 (5–7) Group B: median SAS = 6 (5–7) P = 0.084 OR = 0.84; 95% CI = 0.68–1.03; P = 0.096 No difference in the modified SAS between patients with morbidity and without morbidity Xing et al. (2016), J Thorac Dis, China [8] Retrospective cohort study (level III) Study period: 2008–2010 Total sample size: n = 189 Male/female: 161/28 Mean age: 64.6 ± 9.6 years Comorbidity: hypertension, n = 41; diabetes, n = 11; coronary heart disease, n = 11; COPD, n = 3 Diagnosis: oesophageal malignancy Operative procedures: all thoracotomy SAS point assignment criteria: 0 point: EIBL >600 ml, LMAP <40 mmHg, LHR >85 bpm 1 point: EIBL = 301–600 ml, LMAP = 40–54 mmHg, LHR = 76–85 bpm 2 points: EIBL = 201–300 ml, LMAP = 55–69 mmHg, LHR = 66–75 bpm 3 points: EIBL ≤200 ml, LMAP ≥70 mmHg, LHR = 56–65 bpm 4 points: LHR ≤55 bpm Grouping: Threshold value of SAS = 7 Group A (SAS ≤7): n = 156 Group B (SAS >7): n = 33 Major morbidity (defined as the Clavien–Dindo Grade ≥III complications) Length of stay In-hospital mortality Multivariate analysis of the SAS for predicting postoperative morbidity Rate = 58.2% (n = 110) Group A: 99/156 (63.5%) Group B: 11/33 (33.3%) P = 0.001 Group A: 32.2 ± 22.7 days Group B: 25.4 ± 14.4 days P = 0.030 Rate = 6.9% (n = 13) Group A: 12/156 (7.7%) Group B: 1/33 (3.0%) P = 0.47 SAS ≤7 vs SAS >7: OR = 2.81; 95% CI = 1.11–7.14; P = 0.030 The low SAS was significantly associated with the increased morbidity rate and the prolonged length of stay CI: confidence interval; COPD: chronic obstructive pulmonary disease; EIBL: estimated intraoperative blood loss; LHR: lowest heart rate; LMAP: lowest mean arterial pressure; MIO: minimally invasive oesophagectomy; NSQIP: National Surgical Quality Improvement Program; OR: odds ratio; SAS: surgical Apgar score. RESULTS Janowak et al. [3] performed the earliest retrospective analysis based on a group of 168 patients undergoing oesophagectomy for malignant lesions. On the basis of the clinical practice of oesophagectomy, a modified oesophagectomy SAS system, which had an appropriate adjustment to the original point assignment criteria for EIBL range [2], was utilized intraoperatively (Table 1). An SAS of 6 was determined as the threshold value with regard to major morbidity, which were defined according to the National Surgical Quality Improvement Program adverse events definitions [9]. This cut-off score was used to divide 168 enrolled patients into the high-risk group (SAS ≤ 6: n = 82) and the low-risk group (SAS >6: n = 86). The overall morbidity rate in patients with an SAS of ≤6 was found to be significantly higher than that in patients with an SAS of >6 (45.1 vs 24.4%; P = 0.005). Patients with an SAS of ≤6 had higher rates of pneumonia (18.3 vs 9.3%; P = 0.11), anastomotic leakage (19.5 vs 11.6%; P = 0.20), surgical site infection (23.2 vs 12.8%; P = 0.11), chylothorax (4.9 vs 1.2%; P = 0.20) and 30-day mortality (3.7 vs 1.2%; P = 0.36) than those of patients with an SAS of >6 but without reaching statistical significance. Finally, the multivariate logistic regression analysis confirmed that the SAS ≤6 was a strongly independent predictor for major morbidity following oesophagectomy [odds ratio (OR) 3.75, 95% confidence interval (CI) 1.70–8.26; P = 0.001]. Eto et al. [4] retrospectively reviewed the clinical data of 399 patients undergoing oesophagectomy for malignancies. The authors accepted the original SAS criteria to assign points to each included intraoperative parameter [2] as shown in Table 1. The mean SAS in patients who developed postoperative complications (defined as the Clavien–Dindo Grade ≥III complications) [10] was significantly lower than that in patients without any complication (5.0 ± 0.1 vs 6.0 ± 0.1; P < 0.001). A receiver operating characteristic (ROC) analysis further identified an SAS of 6 to be the optimal cut-off value with reference to postoperative morbidity, at which the joint sensitivity plus specificity was maximal. Given this cut-off, there were 154 patients with an SAS of <6 and 245 patients with an SAS of ≥6, respectively. The rates of overall morbidity (46.1 vs 22.4%; P < 0.001), respiratory complications (18.8 vs 8.3%; P = 0.003), anastomotic leakage (20.8 vs 7.8%; P < 0.001) and surgical site infection (30.5 vs 12.7%; P < 0.001) in patients with an SAS of <6 were all significantly higher than those in patients with an SAS of ≥6. No significant difference was found between these 2 groups in terms of the incidences of recurrent laryngeal nerve paralysis (5.8 vs 2.9%; P = 0.15) and chylothorax (3.9 vs 1.2%; P = 0.090). The multivariate logistic regression analysis demonstrated that the SAS <6 could independently predict the occurrence of postoperative complications (OR 2.88, 95% CI 1.69–4.97; P < 0.001). Giugliano et al. [5] retrospectively evaluated the clinical data of 212 patients undergoing oesophagectomy for both malignant and non-malignant lesions. After adjusting the original point assignment criteria for EIBL range according to the clinical practice of oesophagectomy [2], a modified SAS system was adopted intraoperatively as shown in Table 1. The SASs of all enrolled patients were collapsed into 5 categorizations for further comparative analyses (0–2: n = 5; 3–4: n = 23; 5–6: n = 81; 7–8: n = 96 and 9–10: n = 7). The univariate analysis showed a significant decrease in both Clavien–Dindo Grade ≥II and Grade ≥III complications with the increasing SAS levels (P < 0.001) [10]. In addition, each one category decrease in the SAS was found to be significantly associated with the prolonged length of stay (P < 0.001). Both the patients with the SAS of 0–2 and the patients with an SAS of 3–4 had the highest probability of developing Clavien–Dindo Grade ≥II (0–2: n = 5, rate = 100%; 3–4: n = 17, rate = 73.9%; P < 0.001) and Grade ≥III complications (0–2: n = 3, rate = 60%; 3–4: n = 15, rate = 65.2%; P < 0.001). The patients with an SAS of 9–10 had the lowest rates of Clavien–Dindo Grade ≥II complications (n = 1, rate = 14.3%) and anastomotic leakage (n = 1, rate = 14.3%). No Clavien–Dindo Grade ≥III complication was developed in the patients with an SAS of 9–10. Finally, the multivariate logistic regression analysis indicated that each one category increase in the SAS was significantly associated with the decreased Clavien–Dindo Grade ≥II complications (OR 0.53, 95% CI 0.35–0.79; P = 0.002), Clavien–Dindo Grade ≥III complications (OR 0.50, 95% CI 0.33–0.76; P = 0.001) and in-hospital mortality (OR 0.40, 95% CI 0.19–0.86; P = 0.019). Nakagawa et al. [6] carried out the largest retrospective cohort study based on 400 patients undergoing oesophagectomy for malignant lesions. An original SAS system was utilized to assign points to each estimated parameter during the oesophagectomy (Table 1) [2]. On the basis of an ROC curve, an SAS of 5 was determined as the threshold value with the maximum joint sensitivity plus specificity for predicting risk of morbidity (defined as the Clavien–Dindo Grade ≥III complications) [10]. Then, this cut-off score was applied to divide the entire cohort into the group of patients with an SAS of ≤5 (n = 181) and the group of patients with an SAS of >5 (n = 219). Patients with an SAS of ≤5 had the significantly higher rates of overall morbidity (49.7 vs 25.1%; P < 0.001), respiratory complications (21.5 vs 9.6%; P = 0.001) and gastrointestinal complications (24.9 vs 14.2%; P = 0.008) than those of patients with an SAS of >5. The further multivariate logistic regression analysis demonstrated that an SAS of ≤5 was significantly associated with overall morbidity (OR 2.86, 95% CI 1.85–4.41; P < 0.001), respiratory complications (OR 2.23, 95% CI 1.21–4.10; P = 0.010) and gastrointestinal complications (OR 1.75, 95% CI 1.04–2.95; P = 0.035) after oesophagectomy. Strøyer et al. [7] retrospectively analysed the clinical data of 234 patients undergoing Ivor-Lewis oesophagectomy for malignant oesophagogastric junction adenocarcinoma. The authors adopted an interquartile range for EIBL in their cohort of oesophagectomy to modify the point assignment criteria of the original SAS system [2] as shown in Table 1. The area under the ROC curve for the modified SAS on the prediction of major morbidity (defined as the Clavien–Dindo Grade ≥III complications) [10] was 0.57 (95% CI 0.49–0.65; P = 0.090). The univariate analysis showed no significant difference in the median SAS between patients with complications and patients without complications (P = 0.084). Finally, the modified SAS was not found to have a significant predictive value for major morbidity when evaluated as continuous variables in the multivariate logistic regression analysis (OR 0.84, 95% CI 0.68–1.03; P = 0.096). Xing et al. [8] performed a retrospective analysis based on a cohort of 189 patients undergoing oesophagectomy for malignancies. A tailor-made SAS system that modified the original point assignment criteria for EIBL range based on the clinical practice of oesophagectomy was utilized intraoperatively [2] as shown in Table 1. The threshold value of the modified SAS determined by an ROC analysis was 7 to discriminate whether patients were at the high risk of major morbidity (defined as the Clavien–Dindo Grades III–IV complications) [10]. This cut-off score was used to divide 189 enrolled patients into the high-risk group (SAS ≤7: n = 156) and the low-risk group (SAS >7: n = 33). The major morbidity rate in patients with an SAS of ≤7 was significantly higher than that in patients with an SAS of >7 (63.5 vs 33.3%; P = 0.001). In addition, patients with an SAS of ≤7 had a significantly prolonged length of stay than that of patients with an SAS of >7 (32.2 ± 22.7 vs 25.4 ± 14.4 days; P = 0.030). No significant difference was found in the in-hospital mortality between patients with an SAS of ≤7 and patients with an SAS of >7 (7.7 vs 3.0%; P = 0.47). Finally, the multivariate logistic regression analysis indicated that an SAS of ≤7 was an independent risk factor for major morbidity following oesophagectomy (OR 2.81, 95% CI 1.11–7.14; P = 0.030). CLINICAL BOTTOM LINE A low SAS can serve as an excellent predictor for postoperative complications in patients undergoing oesophagectomy. The rates of major individual complications in patients with a lower SAS are commonly higher than those in patients with a higher SAS. A low SAS may be significantly associated with the prolonged length of stay. The cut-off value of the SAS for morbidity risk is likely to be 6 or less. The SAS system may serve as an effective assessment tool for the prediction of morbidity after oesophagectomy. Conflict of interest: none declared. ACKNOWLEDGEMENTS The authors thank Stanley Crawford, from the Institution of Medical English, West China Medical Center, Sichuan University, Chengdu, China, for his help with the English language editing of this article. REFERENCES 1 Dunning J , Prendergast B , Mackway-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS . Interact CardioVasc Thorac Surg 2003 ; 2 : 405 – 9 . Google Scholar CrossRef Search ADS PubMed 2 Gawande AA , Kwaan MR , Regenbogen SE , Lipsitz SA , Zinner MJ. An Apgar score for surgery . J Am Coll Surg 2007 ; 204 : 201 – 8 . Google Scholar CrossRef Search ADS PubMed 3 Janowak CF , Blasberg JD , Taylor L , Maloney JD , Macke RA. The Surgical Apgar Score in esophagectomy . J Thorac Cardiovasc Surg 2015 ; 150 : 806 – 12 . Google Scholar CrossRef Search ADS PubMed 4 Eto K , Yoshida N , Iwatsuki M , Kurashige J , Ida S , Ishimoto T et al. Surgical Apgar Score predicted postoperative morbidity after esophagectomy for esophageal cancer . World J Surg 2016 ; 40 : 1145 – 51 . Google Scholar CrossRef Search ADS PubMed 5 Giugliano DN , Morgan A , Palazzo F , Leiby BE , Evans NR , Rosato EL et al. Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center . J Surg Oncol 2017 ; 116 : 359 – 64 . Google Scholar CrossRef Search ADS PubMed 6 Nakagawa A , Nakamura T , Oshikiri T , Hasegawa H , Yamamoto M , Kanaji S et al. The Surgical Apgar Score predicts not only short-term complications but also long-term prognosis after esophagectomy . Ann Surg Oncol 2017 ; 24 : 3934 – 46 . Google Scholar CrossRef Search ADS PubMed 7 Strøyer S , Mantoni T , Svendsen LB. Evaluation of the surgical Apgar score in patients undergoing Ivor-Lewis esophagectomy . J Surg Oncol 2017 ; 115 : 186 – 91 . Google Scholar CrossRef Search ADS PubMed 8 Xing XZ , Wang HJ , Qu SN , Huang CL , Zhang H , Wang H et al. The value of esophagectomy surgical Apgar score (eSAS) in predicting the risk of major morbidity after open esophagectomy . J Thorac Dis 2016 ; 8 : 1780 – 7 . Google Scholar CrossRef Search ADS PubMed 9 Khuri SF , Daley J , Henderson W , Barbour G , Lowry P , Irvin G et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care . J Am Coll Surg 1995 ; 180 : 519 – 31 . Google Scholar PubMed 10 Dindo D , Demartines N , Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey . Ann Surg 2004 ; 240 : 205 – 13 . Google Scholar CrossRef Search ADS PubMed © The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)

Interactive CardioVascular and Thoracic Surgery – Oxford University Press

**Published: ** May 9, 2018

Loading...

personal research library

It’s your single place to instantly

**discover** and **read** the research

that matters to you.

Enjoy **affordable access** to

over 18 million articles from more than

**15,000 peer-reviewed journals**.

All for just $49/month

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Read from thousands of the leading scholarly journals from *SpringerNature*, *Elsevier*, *Wiley-Blackwell*, *Oxford University Press* and more.

All the latest content is available, no embargo periods.

## “Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”

Daniel C.

## “Whoa! It’s like Spotify but for academic articles.”

@Phil_Robichaud

## “I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”

@deepthiw

## “My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”

@JoseServera

DeepDyve ## Freelancer | DeepDyve ## Pro | |
---|---|---|

Price | FREE | $49/month |

Save searches from | ||

Create lists to | ||

Export lists, citations | ||

Read DeepDyve articles | Abstract access only | Unlimited access to over |

20 pages / month | ||

PDF Discount | 20% off | |

Read and print from thousands of top scholarly journals.

System error. Please try again!

or

By signing up, you agree to DeepDyve’s Terms of Service and Privacy Policy.

Already have an account? Log in

Bookmark this article. You can see your Bookmarks on your DeepDyve Library.

To save an article, **log in** first, or **sign up** for a DeepDyve account if you don’t already have one.

All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

ok to continue